-
公开(公告)号:US20120010207A1
公开(公告)日:2012-01-12
申请号:US13179585
申请日:2011-07-11
申请人: Andrew Simon Bell , Alan Daniel Brown , Russell Andrew Lewthwaite , Ian Roger Marsh , David Simon Millan , Manuel Perez Pacheco , David James Rawson , Nunzio Sciammetta , Robert Ian Storer , Paul Anthony Stupple , Nigel Alan Swain , Marcel John De Groot
发明人: Andrew Simon Bell , Alan Daniel Brown , Russell Andrew Lewthwaite , Ian Roger Marsh , David Simon Millan , Manuel Perez Pacheco , David James Rawson , Nunzio Sciammetta , Robert Ian Storer , Paul Anthony Stupple , Nigel Alan Swain , Marcel John De Groot
IPC分类号: A61K31/18 , C07D231/12 , C07D233/64 , A61P29/00 , A61K31/415 , A61K31/4164 , A61K31/50 , A61K31/277 , C07C311/51 , C07D237/08
CPC分类号: C07C311/51 , C07C2601/02 , C07D231/12 , C07D233/60 , C07D237/08
摘要: The invention relates to sulfonamide derivatives, to their use in medicine, to compositions containing them, to processes for their preparation and to intermediates used in such processes.More particularly the invention relates to a new sulfonamide Nav1.7 inhibitors of formula (I): or a pharmaceutically acceptable salt thereof, wherein Ar1, X, R1, R2, R3, R4 and R5 are as defined in the description.Nav 1.7 inhibitors are potentially useful in the treatment of a wide range of disorders, particularly pain.
摘要翻译: 本发明涉及磺酰胺衍生物,其在医学上的用途,含有它们的组合物,其制备方法以及在这些方法中使用的中间体。 更具体地,本发明涉及式(I)的新的磺酰胺Nav1.7抑制剂:或其药学上可接受的盐,其中Ar1,X,R1,R2,R3,R4和R5如说明书中所定义。 Nav 1.7抑制剂可用于治疗各种疾病,特别是疼痛。
-
公开(公告)号:US20100222365A1
公开(公告)日:2010-09-02
申请号:US12063281
申请日:2006-07-31
IPC分类号: A61K31/497 , C07D401/14 , A61P15/00 , A61P25/00 , A61P9/00 , A61P1/16 , A61P27/02
CPC分类号: C07D401/14
摘要: The present invention relates to a class of substituted triazoles of formula (I) with activity as oxytocin antagonists, uses thereof, processes for the preparation thereof and compositions containing said inhibitors. These inhibitors have utility in a variety of therapeutic areas including sexual dysfunction, particularly premature ejaculation (P.E.).
摘要翻译: 本发明涉及一类具有活性作为催产素拮抗剂的式(I)的取代三唑,其用途,其制备方法和含有所述抑制剂的组合物。 这些抑制剂可用于各种治疗领域,包括性功能障碍,特别是早泄(P.E.)。
-